Skip to main content
SpringerLink
Log in

Budding Is Useful to Select High-Risk Patients in Stage II Well-Differentiated or Moderately Differentiated Colon Adenocarcinoma

  • Original Contribution
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: Budding at the invasive front of tumors has recently been thought to suggest greater malignant potential of the colorectal carcinoma. We examined whether budding is associated with poor prognosis after curative resection in Stage II and Stage III colon carcinoma. Furthermore, we examined whether budding is useful to select high-risk patients in Stage II colon carcinoma. METHODS: Surgically resected specimens of 196 Stage II and Stage III colon carcinomas were studied. All the resections were curative (R0), and the median postoperative follow-up was 75.5 months. Using hematoxylin-eosin–stained sections, we determined the presence or absence of budding according to Morodomi’s criteria. Routine pathologic findings were also recorded. RESULTS: Budding was detected significantly more frequently in lesions with lymph node metastasis (Stage III) than in lesions without it (Stage II; P < 0.0001). Patients with budding-positive lesions had worse outcome than those with budding-negative lesions: 43 patients (50.6 percent) with budding-positive lesions and 9 (8.1 percent) with budding-negative lesions developed recurrence (P < 0.0001). Patients with budding-positive lesions had a worse prognosis than patients without it (P < 0.0001). Moreover, no significant difference in survival curves was observed between patients with budding-positive Stage II lesions and those with Stage III lesions (P = 0.930). Multivariate analysis revealed budding as the significant prognostic cofactor of postoperative survival in Stage II and Stage III colon carcinoma (P < 0.0001). CONCLUSION: Budding is useful to select high-risk patients in Stage II colon carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  2. CE Ducks (1932) ArticleTitleThe classification of cancer of the rectum J Pathol Bacteriol 35 322–332

    Google Scholar 

  3. S Merkel A Wein K Gunther T Papadopoulos W Hohenberger P Hermanek (2001) ArticleTitleHigh-risk groups of patients with Stage II colon carcinoma Cancer 92 1435–1443

    Google Scholar 

  4. T Imai (1954) ArticleTitleThe growth of human carcinoma. A morphological analysis [in Japanese] Fukuoka Igaku Zasshi 45 72–102

    Google Scholar 

  5. T Morodomi H Isomoto K Shirouzu K Kakegawa K Irie M Morimatsu (1989) ArticleTitleAn index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer Cancer 63 539–543

    Google Scholar 

  6. K Hase C Shatney D Johnson M Trollope M Vierra (1993) ArticleTitlePrognostic value of tumor “budding” in patients with colorectal cancer Dis Colon Rectum 36 627–635

    Google Scholar 

  7. H Ueno J Murphy JR Jass H Mochizuki IC Talbot (2002) ArticleTitleTumor “budding” as an index to estimate the potential of aggressiveness in rectal cancer Histopathology 40 127–132

    Google Scholar 

  8. HC Umpleby DL Ranson RC Williamson (1985) ArticleTitlePeculiarities of mucinous colorectal carcinoma Br J Surg 72 715–718

    Google Scholar 

  9. BD Minsky C Mies TA Rich A Recht JT Chaffey (1987) ArticleTitleColloid carcinoma of the colon and rectum Cancer 60 3103–3112

    Google Scholar 

  10. Y Kanemitsu T Kato T Hirai et al. (2003) ArticleTitleSurvival after curative resection for mucinous adenocarcinoma of the colorectum Dis Colon Rectum 46 160–167

    Google Scholar 

  12. VB Astler FA Coller (1954) ArticleTitleThe prognostic significance of direct extension of carcinoma of the colon and rectum Ann Surg 139 846–852

    Google Scholar 

  13. BD Minsky C Mies TA Rich A Recht (1989) ArticleTitleLymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer Int J Radiat Oncol Biol Phys 17 311–318

    Google Scholar 

  14. JR Jass SB Love JM Northover (1987) ArticleTitleA new prognostic classification of rectal cancer Lancet 2 1303–1306

    Google Scholar 

  15. H Ueno H Mochizuki E Shinto Y Hashiguchi K Hase IC Talbot (2002) ArticleTitleHistologic indices in biopsy specimens for estimating the probability of extended local spread in patients with rectal carcinoma Cancer 94 2882–2891

    Google Scholar 

  16. K Hase CH Shatney H Mochizuki et al. (1995) ArticleTitleLong-term results of curative resection of “minimally invasive” colorectal cancer Dis Colon Rectum 38 19–26

    Google Scholar 

  17. T Okuyama M Oya H Ishikawa (2002) ArticleTitleBudding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma Dis Colon Rectum 45 628–634

    Google Scholar 

  18. JR Jass M Barker L Fraser et al. (2003) ArticleTitleAPC mutation and tumor budding in colorectal cancer J Clin Pathol 56 69–73

    Google Scholar 

  19. JS Thebo AJ Senagore DS Reinhold SR Stapleton (2000) ArticleTitleMolecular staging of colorectal cancer Dis Colon Rectum 43 155–162

    Google Scholar 

  20. CA Purdie J Piris (2000) ArticleTitleHistopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma Histopathology 37 474–475

    Google Scholar 

  21. P Gervaz H Bouzourence JP Cerottini et al. (2001) ArticleTitleDukes B colorectal cancer Dis Colon Rectum 44 364–373

    Google Scholar 

  22. G Burdy Y Panis A Alves J Nemeth A Lavergne-Slove P Valleur (2001) ArticleTitleIdentifying patients with T3-T4 node-negative colon cancer at high risk of recurrence Dis Colon Rectum 44 1682–1688

    Google Scholar 

  23. S Caplin JP Cerottini FT Bosman MT Constanda JC Givel (1998) ArticleTitleFor patients with Dukes’ B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis Cancer 83 666–672

    Google Scholar 

  24. MJ O’Connell JA Laurie M Kahn et al. (1998) ArticleTitleProspectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer J Clin Oncol 16 295–300

    Google Scholar 

  25. N Wolmark H Rockette E Mamounas et al. (1999) ArticleTitleClinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes’ B and C carcinoma of the colon J Clin Oncol 17 3553–3559

    Google Scholar 

  26. E Mamounas S Wieand N Wolmark et al. (1999) ArticleTitleComparative efficacy of adjuvant chemotherapy in patients with Dukes’ B versus Dukes’ C colon cancer J Clin Oncol 17 1349–1355

    Google Scholar 

  27. N Wolmark H Rockett DL Wickerham et al. (1990) ArticleTitleAdjuvant therapy of Dukes’ A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion J Clin Oncol 8 1466–1475

    Google Scholar 

  28. N Wolmark H Rockette B Fisher et al. (1993) ArticleTitleThe benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer J Clin Oncol 11 1879–1887

    Google Scholar 

  29. EP Mamounas (2000) ArticleTitleAdjuvant chemotherapy for stage II colon cancer Eur J Surg Oncol 26 725–729

    Google Scholar 

  30. A Wein EG Hahn S Merkel W Hohenberger (2000) ArticleTitleAdjuvant chemotherapy for stage II (Dukes’ B) colon cancer Eur J Surg Oncol 26 730–732

    Google Scholar 

Download references

Author information

Authors and Affiliations

    Authors
    1. Takashi Okuyama M.D.
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Tetsuro Nakamura M.D.
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Masahiko Yamaguchi M.D.
      View author publications

      You can also search for this author in PubMed Google Scholar

    About this article

    Cite this article

    Okuyama, T., Nakamura, T. & Yamaguchi, M. Budding Is Useful to Select High-Risk Patients in Stage II Well-Differentiated or Moderately Differentiated Colon Adenocarcinoma. Dis Colon Rectum 46, 1400–1406 (2003). https://doi.org/10.1007/s10350-004-6757-0

    Download citation

    • Issue Date:

    • DOI: https://doi.org/10.1007/s10350-004-6757-0

    Keywords

    Search

    Navigation